• Search
  • Login
  • Register
Menu
  • BJMO
  • Home
  • News
  • CongressUpdate
  • Specials
  • Links
All
  • All
  • BJMO articles
  • Blog articles
  • Specials
Forgot Password? Not a member yet? Register here
News > ASCO GI 2023

Category

ASCO GI 2023
  • Health of Tomorrow
  • Healthy Living
  • Corona
  • Medical Research
  • Therapy

ASCO GI 2023

Zolbetuximab plus chemotherapy prolongs survival in CLDN18.2+/HER2- gastric/GEJ adenocarcinoma

Read more
subscribe Latest issue All issues Newsletters
Index latest issue
  • Immunotherapy: a game changer for patients with extensive stage small cell lung cancer
  • Targeted therapy and immunotherapy in early-stage non-small cell lung cancer
  • Antibody-drug conjugates in lung cancer: a paradigm shift on the horizon?
Top

Join our newsletter

  • This field is for validation purposes and should be left unchanged.
  • About BJMO
  • Ads & sponsoring
  • Vacancies
  • Disclaimer
  • Privacy
  • Contact

BJMO is published by Ariez International BV, Westzijde 22, 1506 EE Zaandam, The Netherlands

© BJMO 2023